The MAPK/ERK and PI(3)K pathways additively coordinate the transcription of recombination-activating genes in B lineage cells

Journal of Immunology

Volumn 185, Issue 6, 2010, Pages 3239-3247

  Novak, Rostislav ^a   Jacob, Eyal ^a   Haimovich, Joseph ^b   Avni, Orly ^a   Melamed, Doron ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSCRIPTION FACTOR FKHR; CROSS LINKING REAGENT; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL CYCLE; CELL GROWTH; CELL LINEAGE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; DOWN REGULATION; ENZYMOLOGY; GENE; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; B-LYMPHOCYTE SUBSETS; CELL LINE, TUMOR; CELL LINEAGE; CROSS-LINKING REAGENTS; DOWN-REGULATION; GENES, RAG-1; LIGANDS; MAP KINASE SIGNALING SYSTEM; MICE; PHOSPHATIDYLINOSITOL 3-KINASE; PROTEIN BINDING; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 78649888223     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001430     Document Type: Article

References (70)

1. Grawunder, U., T. M. J. Leu, D. G. Schatz, A. Werner, A. G. Rolink, F. Melchers, and T. H. Winkler. 1995. Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement. Immunity 3: 601-608.
2. Shinkai, Y., G. Rathbun, K.-P. Lam, E. M. Oltz, V. Stewart, M. Mendelsohn, J. Charron, M. Datta, F. Young, A. M. Stall, and F. W. Alt. 1992. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68: 855-867.
3. Mombaerts, P., J. Iacomini, R. S. Johnson, K. Herrup, S. Tonegawa, and V. E. Papaioannou. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877.
4. Melamed, D., and D. Nemazee. 1997. Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of developmental arrest. Proc. Natl. Acad. Sci. USA 94: 9267-9272.
5. Tiegs, S. L., D. M. Russell, and D. Nemazee. 1993. Receptor editing in selfreactive bone marrow B cells. J. Exp. Med. 177: 1009-1020.
6. Gay, D., T. Saunders, S. Camper, and M. Weigert. 1993. Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177: 999-1008.
7. Keren, Z., E. Diamant, O. Ostrovsky, E. Bengal, and D. Melamed. 2004. Modification of ligand-independent B cell receptor tonic signals activates receptor editing in immature B lymphocytes. J. Biol. Chem. 279: 13418-13424.
8. Diamant, E., Z. Keren, and D. Melamed. 2005. CD19 regulates positive selection and maturation in B lymphopoiesis: lack of CD19 imposes developmental arrest of immature B cells and consequential stimulation of receptor editing. Blood 105: 3247-3254.
9. - bone marrow B cells in vitro. Immunity 6: 429-436.
10. Melamed, D., R. J. Benschop, J. C. Cambier, and D. Nemazee. 1998. Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor selection. Cell 92: 173-182.
11. Han, S., B. Zheng, D. G. Schatz, E. Spanopoulou, and G. Kelsoe. 1996. Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells. Science 274: 2094-2097.
12. Hikida, M., M. Mori, T. Takai, K. Tomochika, K. Hamatani, and H. Ohmori. 1996. Reexpression of RAG-1 and RAG-2 genes in activated mature mouse B cells. Science 274: 2092-2094.
13. Hertz, M., V. Kouskoff, T. Nakamura, and D. Nemazee. 1998. V(D)J recombinase induction in splenic B lymphocytes is inhibited by antigen-receptor signalling. [see comments] Nature 394: 292-295.
14. Meffre, E., F. Papavasiliou, P. Cohen, O. de Bouteiller, D. Bell, H. Karasuyama, C. Schiff, J. Banchereau, Y. J. Liu, and M. C. Nussenzweig. 1998. Antigen receptor engagement turns off the V(D)J recombination machinery in human tonsil B cells. J. Exp. Med. 188: 765-772.
15. Ohnishi, K., and F. Melchers. 2003. The nonimmunoglobulin portion of λ5 mediates cell-autonomous pre-B cell receptor signaling. Nat. Immunol. 4: 849-856.
16. Lam, K. P., R. Kühn, and K. Rajewsky. 1997. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90: 1073-1083.
17. Kraus, M., M. B. Alimzhanov, N. Rajewsky, and K. Rajewsky. 2004. Survival of resting mature B lymphocytes depends on BCR signaling via the Igα/β heterodimer. Cell 117: 787-800.
18. Srinivasan, L., Y. Sasaki, D. P. Calado, B. Zhang, J. H. Paik, R. A. DePinho, J. L. Kutok, J. F. Kearney, K. L. Otipoby, and K. Rajewsky. 2009. PI3 kinase signals BCR-dependent mature B cell survival. Cell 139: 573-586.
19. Monroe, J. G. 2006. ITAM-mediated tonic signalling through pre-BCR and BCR complexes. Nat. Rev. Immunol. 6: 283-294.
20. Edry, E., and D. Melamed. 2004. Receptor editing in positive and negative selection of B lymphopoiesis. J. Immunol. 173: 4265-4271.
21. Kuo, T. C., and M. S. Schlissel. 2009. Mechanisms controlling expression of the RAG locus during lymphocyte development. Curr. Opin. Immunol. 21: 173-178.
22. Shivtiel, S., N. Leider, O. Sadeh, Z. Kraiem, and D. Melamed. 2002. Impaired light chain allelic exclusion and lack of positive selection in immature B cells expressing incompetent receptor deficient of CD19. J. Immunol. 168: 5596-5604.
23. Verkoczy, L., B. Duong, P. Skog, D. Aït-Azzouzene, K. Puri, J. L. Vela, and D. Nemazee. 2007. Basal B cell receptor-directed phosphatidylinositol 3-kinase signaling turns off RAGs and promotes B cell-positive selection. J. Immunol. 178: 6332-6341.
24. Llorian, M., Z. Stamataki, S. Hill, M. Turner, and I.-L. Mårtensson. 2007. The PI (3)K p110δ is required for down-regulation of RAG expression in immature B cells. J. Immunol. 178: 1981-1985.
25. Herzog, S., E. Hug, S. Meixlsperger, J.-H. Paik, R. A. DePinho, M. Reth, and H. Jumaa. 2008. SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathway. Nat. Immunol. 9: 623-631.
26. Amin, R. H., and M. S. Schlissel. 2008. Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nat. Immunol. 9: 613-622.
27. Dengler, H. S., G. V. Baracho, S. A. Omori, S. Bruckner, K. C. Arden, D. H. Castrillon, R. A. DePinho, and R. C. Rickert. 2008. Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation. Nat. Immunol. 9: 1388-1398.
28. Meade, J., C. Fernandez, and M. Turner. 2002. The tyrosine kinase Lyn is required for B cell development beyond the T1 stage in the spleen: rescue by over-expression of Bcl-2. Eur. J. Immunol. 32: 1029-1034.
29. Li, X., and R. H. Carter. 1998. Convergence of CD19 and B cell antigen receptor signals at MEK1 in the ERK2 activation cascade. J. Immunol. 161: 5901-5908.
30. Roose, J. P., M. Diehn, M. G. Tomlinson, J. Lin, A. A. Alizadeh, D. Botstein, P. O. Brown, and A. Weiss. 2003. T cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression. PLoS Biol. 1: e53.
31. Mazari, L., M. Ouarzane, and M. Zouali. 2007. Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus. Proc. Natl. Acad. Sci. USA 104: 6317-6322.
32. Bergman, Y., and J. Haimovich. 1978. B lymphocytes contain three species of mu chains. Eur. J. Immunol. 8: 876-880.
33. κ segment in a murine B cell line. J. Exp. Med. 170: 1-13.
34. Maës, J., Y. Caspi, F. Rougeon, J. Haimovich, and M. Goodhardt. 2000. Secondary V(D)J rearrangements and B cell receptor-mediated down-regulation of recombination activating gene-2 expression in a murine B cell line. J. Immunol. 165: 703-709.
35. Bergman, Y., and J. Haimovich. 1977. Characterization of a carcinogen-induced murine B lymphocyte cell line of C3H/eB origin. Eur. J. Immunol. 7: 413-417.
36. Kövesdi, D., G. Koncz, R. Iványi-Nagy, Y. Caspi, M. Ishiai, T. Kurosaki, J. Gergely, J. Haimovich, and G. Sármay. 2002. Developmental differences in B cell receptor-induced signal transduction. Cell. Signal. 14: 563-572.
37. Frankel, P., A. Aronheim, E. Kavanagh, M. S. Balda, K. Matter, T. D. Bunney, and C. J. Marshall. 2005. RalA interacts with ZONAB in a cell density-dependent manner and regulates its transcriptional activity. EMBO J. 24: 54-62.
38. Hambleton, J., M. McMahon, and A. L. DeFranco. 1995. Activation of Raf-1 and mitogen-activated protein kinase in murine macrophages partially mimics lipopolysaccharide-induced signaling events. J. Exp. Med. 182: 147-154.
39. Kinoshita, S., B. K. Chen, H. Kaneshima, and G. P. Nolan. 1998. Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells. Cell 95: 595-604.
40. Wang, H., J. Feng, C. F. Qi, Z. Li, H. C. Morse, III, and S. H. Clarke. 2007. Transitional B cells lose their ability to receptor edit but retain their potential for positive and negative selection. J. Immunol. 179: 7544-7552.
41. Xu, C. R., and A. J. Feeney. 2009. The epigenetic profile of Ig genes is dynamically regulated during B cell differentiation and is modulated by pre-B cell receptor signaling. J. Immunol. 182: 1362-1369.
42. Scheinman, E. J., and O. Avni. 2009. Transcriptional regulation of Gata3 in T helper cells by the integrated activities of transcription factors downstream of the interleukin-4 receptor and T cell receptor. J. Biol. Chem. 284: 3037-3048.
43. Hu, H., B. Wang, M. Borde, J. Nardone, S. Maika, L. Allred, P. W. Tucker, and A. Rao. 2006. Foxp1 is an essential transcriptional regulator of B cell development. Nat. Immunol. 7: 819-826.
44. Hsu, L. Y., J. Lauring, H. E. Liang, S. Greenbaum, D. Cado, Y. Zhuang, and M. S. Schlissel. 2003. A conserved transcriptional enhancer regulates RAG gene expression in developing B cells. Immunity 19: 105-117.
45. Borghesi, L., J. Aites, S. Nelson, P. Lefterov, P. James, and R. Gerstein. 2005. E47 is required for V(D)J recombinase activity in common lymphoid progenitors. J. Exp. Med. 202: 1669-1677.
46. Bain, G., C. B. Cravatt, C. Loomans, J. Alberola-Ila, S. M. Hedrick, and C. Murre. 2001. Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade. Nat. Immunol. 2: 165-171.
47. Nie, L., M. Xu, A. Vladimirova, and X. H. Sun. 2003. Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities. EMBO J. 22: 5780-5792.
48. King, A. M., E. Van der Put, B. B. Blomberg, and R. L. Riley. 2007. Accelerated Notch-dependent degradation of E47 proteins in aged B cell precursors is associated with increased ERK MAPK activation. J. Immunol. 178: 3521-3529.
49. Beck, K., M. M. Peak, T. Ota, D. Nemazee, and C. Murre. 2009. Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci. J. Exp. Med. 206: 2271-2284.
50. Stein, B., and A. S. Baldwin, Jr. 1993. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-κB. Mol. Cell. Biol. 13: 7191-7198.
51. κ gene rearrangements in a murine B cell lymphoma: an explantation for idiotypic heterogeneity. J. Exp. Med. 168: 1607-1620.
52. Shaw, A. C., W. Swat, L. Davidson, and F. W. Alt. 1999. Induction of Ig light chain gene rearrangement in heavy chain-deficient B cells by activated Ras. Proc. Natl. Acad. Sci. USA 96: 2239-2243.
53. Mandal, M., S. E. Powers, K. Ochiai, K. Georgopoulos, B. L. Kee, H. Singh, and M. R. Clark. 2009. Ras orchestrates exit from the cell cycle and light-chain recombination during early B cell development. Nat. Immunol. 10: 1110-1117.
54. Richards, J. D., S. H. Davé, C. H. Chou, A. A. Mamchak, and A. L. DeFranco. 2001. Inhibition of the MEK/ERK signaling pathway blocks a subset of B cell responses to antigen. J. Immunol. 166: 3855-3864.
55. Hayden, M. S., and S. Ghosh. 2004. Signaling to NF-κB. Genes Dev. 18: 2195-2224.
56. Youle, R. J., and A. Strasser. 2008. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9: 47-59.
57. Hauser, J., N. Sveshnikova, A. Wallenius, S. Baradaran, J. Saarikettu, and T. Grundström. 2008. B-cell receptor activation inhibits AID expression through calmodulin inhibition of E-proteins. Proc. Natl. Acad. Sci. USA 105: 1267-1272.
58. κ rearrangement. J. Exp. Med. 200: 1205-1211.
59. Greenbaum, S., and Y. Zhuang. 2002. Identification of E2A target genes in B lymphocyte development by using a gene tagging-based chromatin immunoprecipitation system. Proc. Natl. Acad. Sci. USA 99: 15030-15035.
60. Romanow, W. J., A. W. Langerak, P. Goebel, I. L. Wolvers-Tettero, J. J. van Dongen, A. J. Feeney, and C. Murre. 2000. E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol. Cell 5: 343-353.
61. Bain, G., E. C. Maandag, D. J. Izon, D. Amsen, A. M. Kruisbeek, B. C. Weintraub, I. Krop, M. S. Schlissel, A. J. Feeney, M. van Roon, et al. 1994. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79: 885-892.
62. Quong, M. W., A. Martensson, A. W. Langerak, R. R. Rivera, D. Nemazee, and C. Murre. 2004. Receptor editing and marginal zone B cell development are regulated by the helix-loop-helix protein, E2A. J. Exp. Med. 199: 1101-1112.
63. Mandel, E. M., and R. Grosschedl. 2010. Transcription control of early B cell differentiation. Curr. Opin. Immunol. 22: 161-167.
64. Shankar, S., Q. Chen, and R. K. Srivastava. 2008. Inhibition of PI(3)K/AKT and MEK/ERK pathways act synergistically to enhance antiangiogenic effects of EGCG through activation of FOXO transcription factor. J. Mol. Signal. 3: 7.
65. Asada, S., H. Daitoku, H. Matsuzaki, T. Saito, T. Sudo, H. Mukai, S. Iwashita, K. Kako, T. Kishi, Y. Kasuya, and A. Fukamizu. 2007. Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1. Cell. Signal. 19: 519-527.
66. Engelman, J. A., L. Chen, X. Tan, K. Crosby, A. R. Guimaraes, R. Upadhyay, M. Maira, K. McNamara, S. A. Perera, Y. Song, et al. 2008. Effective use of PI (3)K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers. Nat. Med. 14: 1351-1356.
67. Neale, G. A. M., T. J. Fitzgerald, and R. M. Goorha. 1992. Expression of the V(D)J recombinase gene RAG-1 is tightly regulated and involves both transcriptional and post-transcriptional controls. Mol. Immunol. 29: 1457-1466.
68. Ma, A., P. Fisher, R. Dildrop, E. Oltz, G. Rathbun, P. Achacoso, A. Stall, and F. W. Alt. 1992. Surface IgM mediated regulation of RAG gene expression in Eμ-N-myc B cell lines. EMBO J. 11: 2727-2734.
69. Verkoczy, L. K., B. J. Stiernhdm, and N. L. Berinstein. 1995. Up-regulation of recombination activating gene expression by signal transduction through the surface Ig receptor. J. Immunol. 154: 5136-5143.
70. Verkoczy, L., D. Aït-Azzouzene, P. Skog, A. Märtensson, J. Lang, B. Duong, and D. Nemazee. 2005. A role for nuclear factor κB/rel transcription factors in the regulation of the recombinase activator genes. Immunity 22: 519-531.